CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was the target of a large drop in short interest during the month of April. As of April 30th, there was short interest totaling 19,064 shares, a drop of 39.2% from the April 15th total of 31,352 shares. Based on an average daily trading volume, of 140,854 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.
CochLear Price Performance
Shares of CochLear stock opened at $34.40 on Friday. CochLear has a fifty-two week low of $31.82 and a fifty-two week high of $105.60. The firm has a fifty day moving average price of $52.47 and a two-hundred day moving average price of $74.96.
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. UBS Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. Zacks Research upgraded shares of CochLear to a “hold” rating in a research note on Friday, April 17th. Finally, Royal Bank Of Canada upgraded shares of CochLear from a “hold” rating to a “moderate buy” rating in a research note on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy”.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Further Reading
- Five stocks we like better than CochLear
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
